NP Life Sciences Health Industry Group Inc. (ACAT): Shareholders' Equity
Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$16.4K
As of 2023-12-31
-46.0%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $16.4K | -15.2% | 2024-04-16, Balance as of period end |
| 2022-12-31 | $19.3K | -49.4% | 2024-04-16, Balance as of period end |
| 2021-12-31 | $38.2K | -63.2% | 2023-04-18, Balance as of period end |
| 2020-12-31 | $103.8K | -55.8% | 2022-04-15, Balance as of period end |
| 2019-12-31 | $234.9K | n/a | 2021-04-15, Balance as of period end |